A proudly Canadian innovative company, Pillcheck was recently featured in an exclusive interview with Made in CA. In the interview, Pillcheck CEO Veronika Litinski talks about the inspiration behind our pharmacogenetic (PGx) service, how we help individuals and their doctors use DNA-guided prescribing to achieve effective therapy faster, and our vision to make PGx actionable and accessible for everyone.
Read the full interview at https://madeinca.ca/veronika-litinski-pillcheck/.
Use Pillcheck to avoid side effects and feel better sooner
ORDER NOW
-
Veronika is a medicinal chemist by training and first approached the health sector through cancer research at Lawrence Livermore Labs in Berkeley. Subsequently, she worked in capital markets and invested in innovative companies at GATX Capital in San Francisco. Veronika moved to Canada in 2004, where she joined the new MaRS innovation hub in Toronto. During their start-up phase, she was Director of the Venture Group, the ‘engine room’ of MaRS. Later she was Practice Lead for Health, working in one of the most complex and socially important sectors of our economy. Veronika also piloted the launch of Congniciti, a brain health company developed by Baycrest Hospital. She is currently the CEO of GeneYouIn and a leader in bringing precision medicine to health plans and individuals globally.